Lv21
154 积分 2024-04-29 加入
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
1小时前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
18天前
已完结
Efficacy and safety of dabrafenib plus trametinib in pediatric versus adult gliomas: a systematic review and meta-analysis
1个月前
已完结
The safety and efficacy of dabrafenib and trametinib in patients with glioma: A systematic review and meta-analysis
1个月前
已完结
Organoids and organs-on-chips: Recent advances, applications in drug development, and regulatory challenges
2个月前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
2个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
2个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission
2个月前
已完结
SARM1 in the pathogenesis of immune-related disease
2个月前
已完结
Deletion of murine Sarm1 results in a microenvironment that delays peripheral nerve regeneration after injury
2个月前
已完结
皖公网安备34019202002308
